185 related articles for article (PubMed ID: 21681055)
1. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.
Chao C; Xu L; Abrams DI; Towner WJ; Horberg MA; Leyden WA; Silverberg MJ
AIDS; 2011 Sep; 25(14):1771-7. PubMed ID: 21681055
[TBL] [Abstract][Full Text] [Related]
2. Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
Ye X; Zhang G; Righolt C; Johnston JB; Banerji V; Gibson SB; Mahmud SM
Int J Cancer; 2018 Aug; 143(4):971-979. PubMed ID: 29524215
[TBL] [Abstract][Full Text] [Related]
3. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
[TBL] [Abstract][Full Text] [Related]
4. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
7. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
Liebow M; Larson MC; Thompson CA; Nowakowski GS; Call TG; Macon WR; Kay NE; Habermann TM; Slager SL; Cerhan JR
Int J Cancer; 2021 Aug; 149(3):535-545. PubMed ID: 33644854
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
[TBL] [Abstract][Full Text] [Related]
10. Markers of microbial translocation and risk of AIDS-related lymphoma.
Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin lymphoma in Uganda: a case-control study.
Parkin DM; Garcia-Giannoli H; Raphael M; Martin A; Katangole-Mbidde E; Wabinga H; Ziegler J
AIDS; 2000 Dec; 14(18):2929-36. PubMed ID: 11153674
[TBL] [Abstract][Full Text] [Related]
12. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
[TBL] [Abstract][Full Text] [Related]
13. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
16. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
[TBL] [Abstract][Full Text] [Related]
17. Role of zidovudine antiretroviral therapy in the pathogenesis of acquired immunodeficiency syndrome-related lymphoma.
Levine AM; Bernstein L; Sullivan-Halley J; Shibata D; Mahterian SB; Nathwani BN
Blood; 1995 Dec; 86(12):4612-6. PubMed ID: 8541552
[TBL] [Abstract][Full Text] [Related]
18. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
19. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
